Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
115.09
+4.30 (3.88%)
At close: Apr 28, 2026, 4:00 PM EDT
115.90
+0.81 (0.70%)
After-hours: Apr 28, 2026, 4:28 PM EDT
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nutex Health stock have an average target of 252.5, with a low estimate of 205 and a high estimate of 300. The average target predicts an increase of 119.39% from the current stock price of 115.09.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 26, 2025.
Analyst Ratings
The average analyst rating for Nutex Health stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $225 → $205 | Strong Buy | Maintains | $225 → $205 | +78.12% | Aug 26, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $300 | Strong Buy | Reiterates | $300 | +160.67% | Jul 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $225 | Strong Buy | Maintains | $100 → $225 | +95.50% | May 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $150 → $300 | Strong Buy | Maintains | $150 → $300 | +160.67% | May 15, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $60 → $150 | Strong Buy | Maintains | $60 → $150 | +30.33% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
928.83M
from 875.26M
Increased by 6.12%
Revenue Next Year
966.36M
from 928.83M
Increased by 4.04%
EPS This Year
19.34
from 10.48
Increased by 84.57%
EPS Next Year
23.17
from 19.34
Increased by 19.78%
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 1.0B | 1.0B |
| Avg | 928.8M | 966.4M |
| Low | 839.0M | 920.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 18.8% | 8.0% |
| Avg | 6.1% | 4.0% |
| Low | -4.1% | -0.9% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 20.77 | 27.24 |
| Avg | 19.34 | 23.17 |
| Low | 17.20 | 19.10 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 98.2% | 40.8% |
| Avg | 84.6% | 19.8% |
| Low | 64.1% | -1.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.